Focal segmental glomerulosclerosis historical perspective: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
| (11 intermediate revisions by 4 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Focal segmental glomerulosclerosis}} | {{Focal segmental glomerulosclerosis}} | ||
{{CMG}}, {{APM}}; {{AE}} {{MKA}}, {{MKK}}, {{OO}} | |||
==Overview== | |||
Focal segmental glomerulosclerosis (FSGS) was discovered by Theodor Fahr, a German [[pathologist]], in 1925, and he referred to it as "[[lipoid nephrosis]] with [[degeneration]]", showing a clear association to [[minimal change disease]]. In 1957, FSGS was then described by Dr. Arnold Rich, a [[pathologist]] at [[Johns Hopkins University School of Medicine|Johns Hopkins University]]. | |||
==Historical Perspective== | ==Historical Perspective== | ||
===Discovery=== | |||
*Focal segmental glomerulosclerosis (FSGS) was first discovered by Theodor Fahr, a German [[pathologist]], in 1925.<ref>{{cite book | last = Fahr |first = T | authorlink = |coauthors = | title = Pathologische anatomie des morbus brightii. In: Fahr T, Gruber GB, Koch M, et al. eds. Harnorgane Männliche Geschlechtsorgane.| publisher = Springer |date = 1925 | location = Vienna| pages = 156-472 | url = | doi = | id = | isbn = }}</ref> | |||
*He referred to it as "[[lipoid nephrosis]] with [[degeneration]]", showing a clear association to [[minimal change disease]].<ref>{{cite book | last = Fahr |first = T | authorlink = |coauthors = | title = Pathologische anatomie des morbus brightii. In: Fahr T, Gruber GB, Koch M, et al. eds. Harnorgane Männliche Geschlechtsorgane.| publisher = Springer |date = 1925 | location = Vienna| pages = 156-472 | url = | doi = | id = | isbn = }}</ref> | |||
*In 1957, FSGS was then described by Dr. Arnold Rich, a [[pathologist]] at [[Johns Hopkins University School of Medicine|Johns Hopkins University]].<ref name="pmid13426687">{{cite journal| author=RICH AR| title=A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. | journal=Bull Johns Hopkins Hosp | year= 1957 | volume= 100 | issue= 4 | pages= 173-86 | pmid=13426687 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=13426687 }} </ref> | |||
*In 1970, Jacob Churg and colleagues finally classified FSGS as a unique [[renal]] [[glomerulopathy]] in the " [[Pathology]] of the [[Nephrotic Syndrome]] in Children: Report for the International Study of [[Kidney]] Disease in Children" in view of its clinical and [[pathological]] features, and its [[steroid]]-[[resistance]] in comparison to [[minimal change disease]].<ref name="pmid4193942">{{cite journal| author=Churg J, Habib R, White RH| title=Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children. | journal=Lancet | year= 1970 | volume= 760 | issue= 1 | pages= 1299-302 | pmid=4193942 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4193942 }} </ref> | |||
==References== | ==References== | ||
| Line 11: | Line 20: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Medicine]] | |||
[[Category:Nephrology]] | |||
Latest revision as of 21:46, 29 July 2020
|
Focal segmental glomerulosclerosis Microchapters |
|
Differentiating Focal segmental glomerulosclerosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Focal segmental glomerulosclerosis historical perspective On the Web |
|
American Roentgen Ray Society Images of Focal segmental glomerulosclerosis historical perspective |
|
FDA on Focal segmental glomerulosclerosis historical perspective |
|
CDC on Focal segmental glomerulosclerosis historical perspective |
|
Focal segmental glomerulosclerosis historical perspective in the news |
|
Blogs on Focal segmental glomerulosclerosis historical perspective |
|
Directions to Hospitals Treating Focal segmental glomerulosclerosis |
|
Risk calculators and risk factors for Focal segmental glomerulosclerosis historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [3], Manpreet Kaur, MD [4], Olufunmilola Olubukola M.D.[5]
Overview
Focal segmental glomerulosclerosis (FSGS) was discovered by Theodor Fahr, a German pathologist, in 1925, and he referred to it as "lipoid nephrosis with degeneration", showing a clear association to minimal change disease. In 1957, FSGS was then described by Dr. Arnold Rich, a pathologist at Johns Hopkins University.
Historical Perspective
Discovery
- Focal segmental glomerulosclerosis (FSGS) was first discovered by Theodor Fahr, a German pathologist, in 1925.[1]
- He referred to it as "lipoid nephrosis with degeneration", showing a clear association to minimal change disease.[2]
- In 1957, FSGS was then described by Dr. Arnold Rich, a pathologist at Johns Hopkins University.[3]
- In 1970, Jacob Churg and colleagues finally classified FSGS as a unique renal glomerulopathy in the " Pathology of the Nephrotic Syndrome in Children: Report for the International Study of Kidney Disease in Children" in view of its clinical and pathological features, and its steroid-resistance in comparison to minimal change disease.[4]
References
- ↑ Fahr, T (1925). Pathologische anatomie des morbus brightii. In: Fahr T, Gruber GB, Koch M, et al. eds. Harnorgane Männliche Geschlechtsorgane. Vienna: Springer. pp. 156–472.
- ↑ Fahr, T (1925). Pathologische anatomie des morbus brightii. In: Fahr T, Gruber GB, Koch M, et al. eds. Harnorgane Männliche Geschlechtsorgane. Vienna: Springer. pp. 156–472.
- ↑ RICH AR (1957). "A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis". Bull Johns Hopkins Hosp. 100 (4): 173–86. PMID 13426687.
- ↑ Churg J, Habib R, White RH (1970). "Pathology of the nephrotic syndrome in children: a report for the International Study of Kidney Disease in Children". Lancet. 760 (1): 1299–302. PMID 4193942.